[Skip to Navigation]
Sign In
Viewpoint
June 5, 2018

Value-Based Pricing and Patient Access for Specialty Drugs

Author Affiliations
  • 1University of California, Berkeley
  • 2Novartis Pharmaceuticals Corp, East Hanover, New Jersey
  • 3Institute for Clinical and Economic Review, Boston, Massachusetts
JAMA. 2018;319(21):2169-2170. doi:10.1001/jama.2018.5367
Add or change institution
×